Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Space Summit 2023: Chips in Space

Space Summit 2023: Chips in Space Agenda

Co-Located Conference Agendas

Extracellular Vesicles 2023: Drug Delivery, Biologics & Therapeutics | Extracellular Vesicles 2023: Technologies, Biomarker Cargo & Diagnostics | Microphysiological Systems 2023: A Deep Dive into Technologies & Applications | Space Summit 2023: Chips in Space | 

Print Agenda

Wednesday, 26 July 2023

Please View Details of Programming under the MPS Website

Thursday, 27 July 2023


Morning Coffee and Networking in the Exhibit Hall


Michael RobertsKeynote Presentation

Biomanufacturing and In-Space Production Applications on the ISS National Lab
Michael Roberts, Chief Scientific Officer, International Space Station National Laboratory, United States of America

NASA and the ISS National Laboratory are enabling the commercial development of low-Earth orbit by sponsoring both fundamental research and the in-space manufacturing of advanced materials and biological products that improve life on Earth. As the International Space Station continues to offer access to the unique benefits of a microgravity laboratory, producing breakthrough research as well as new and improved products and technologies, it is also pioneering the path forward for the transition to commercially LEO platforms.


Jana StoudemireConference Chair

Humanity’s Next Chapter
Jana Stoudemire, Director, In-Space Manufacturing, Axiom Space, United States of America


Morning Coffee Break and Networking in the Exhibit Hall


The Orbital Age
Bill McLamb, Payload Systems Lead, Sierra Space, United States of America


DNA-Inspired Janus Base Nanomaterials for Cartilage Tissue Chip Applications
Yupeng Chen, Associate Professor, University of Connecticut, United States of America

Absence of biomechanical loading in microgravity can result in articular cartilage degeneration. Once damaged, cartilage has very limited self-regeneration. Therefore, many biomaterial scaffolds have been developed for cartilage tissue engineering. Conventional solid scaffolds are not injectable so they have limitations for applications in “difficult-to-reach” locations, such as microchannels of tissue chips or deep-tissue damage; hydrogels are semisolid materials so they don’t have solid surface for cell anchorage which could be a limitation in space. To overcome this challenge, we have developed a family of self-assembled scaffolds, named Janus base nano-matrices (JBNms). JBNms are formed by the self-assembly between Janus base nanotubes (JBNts, non-covalent nanotubes mimicking DNA base pairs) and extracellular matrix proteins (such as matrilin, a cartilage specific protein). We have also found that the JBNm presented synergistic functions from JBNts and matrilin, which can create a microenvironment selectively promoting chondrogenic differentiation of stem cells. We have demonstrated that the JBNm can significantly improve longevity and reusability of cartilage tissue chips as while as growth plate cartilage regeneration in a preclinical animal model. Therefore, the JBNm is a versatile scaffold suitable for cartilage tissue engineering and tissue chip applications on Earth and in space.


Applying Analytics to Muscle Tissue Chip Real-Time Biomechanics for In-Space Biomonitoring of Tissue Degradation
Siobhan Malany, Associate Professor, University of Florida and Founder, Micro-gRx, United States of America

Tissue-on-chip (TOC) platforms are microscale, perusable devices mimicking native human biology that are revolutionizing drug discovery and development. Space-based TOCs offer an approach to advance our understanding of the value microgravity can have in more accurately modeling diseases, particularly those related to aging as the space environment is a novel stressor. Through repeated access to the International Space Station, we have advanced the development of an autonomous human muscle-on-chip drug development platform that incorporates real-time muscle biomechanics monitoring. Our interest lies in using space to monitor the effects of microgravity on the muscle TOC which may mimic the salient features of age-related muscle atrophy in a faster timescale. Advancing this technology from fundamental research to commercial viability requires more robust validation of translational and predictive in vivo-like biology.  The unmet medical need is a standardized platform that can provide a solid reference and evaluate patient-specific tissue pathophysiological responses to potential therapeutics in real-time. In this presentation, we describe the collaborative approach by the University of Florida, Microg-Rx, and G-SPACE to develop computer vision-based analytics to extract microstructural information related to intrinsic tissue properties that will facilitate understanding of tissue degradation over time as a further indication of accelerated aging in space. The application of machine learning will serve to increase the technology maturation of TOC platforms and eventually validate the tech platform as a commercial product. Muscles of aged individuals considered sarcopenic, undergo significant muscle loss and a decrease in strength due to a period of inactivity, injury, or illness, which is associated with increased tissue degradation and metabolic changes. With an increasingly aging population, sarcopenia is an enormous healthcare burden and there are currently no FDA-approved therapeutics to treat this clinical disease progression. We have incorporated human 3D skeletal myobundles derived from biopsies from younger and older adult volunteers into the Space Tango CubeLabTM designed to autonomously control fluid exchange, electrical pulse generation, imaging, and video recording. On SpaceX CRS-25, these muscle TOCs were electrically stimulated with 3V, 2Hz, 2msec pulse every 12hr to demonstrate real-time functional skeletal muscle biomechanics in microgravity. On SpaceX CRS-26, these electrically stimulated muscle TOCs were delivered an atrophy natural product. An important feature of our payload is the real-time monitoring and image collection of the contractile function.  The data downlinked from the ISS was analyzed by digital image correlation to determine the fold-displacement prior to and during electrical stimulation as a measure of contractile function. A preliminary comparative analysis of image series collected on TOC samples in microgravity versus ground controls was performed. The ability to decipher intrinsic muscle properties from muscle contractile function will facilitate validation of the TOC technology real-time analytics platform for decision-making of drug testing.


Networking Luncheon in the Exhibit Hall -- Network with the Exhibitors and Engage with Colleagues

Add to Calendar ▼2023-07-26 00:00:002023-07-27 00:00:00Europe/LondonSpace Summit 2023: Chips in SpaceSpace Summit 2023: Chips in Space in Orlando, FloridaOrlando,